Blood-Brain Barrier Technologies and Global Markets: PHM075A

Blood-Brain Barrier Technologies and Global Markets

Report Code: PHM075A

Publish Date: Mar 2011

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for blood-brain barrier (BBB) technology for therapeutics amounted to $12.3 million in 2010 and will reach $387 million by 2015, a compound annual growth rate (CAGR) of 99.3%.

SCOPE OF REPORT

The scope of this study encompasses companies that develop technologies to enable the crossing of the BBB and drug development in which a quality of the development is enabling the crossing of the BBB in cases in which passage was previously impossible often due to size. BCC analyzes each technology, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next 5 years. Technological issues, including the latest trends, are discussed.

ABOUT THE AUTHOR

Kim Lawson is a graduate of Mount Holyoke College with a degree in English Literature. She acquired experience as a healthcare journalist, including working for John Wiley & Sons for years as a print reporter, before serving as a research analyst in a small market research firm that focused on pharmaceuticals and biotechnology in the Research Triangle Park area of North Carolina. Before joining that firm, Kim published two reports on emerging and established diagnostics and therapeutics for benign and cancerous breast disease.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com

[+] Show Chapter Details

Title/Chapter Name	Pages	Member Price
Full Report: Blood-Brain Barrier Technologies and Global Markets	134	Free
Chapter- 1: INTRODUCTION	3	Free
STUDY GOALS AND OBJECTIVES REASONS FOR DOING THIS STUDY SCOPE OF REPORT INTENDED AUDIENCE METHODOLOGY INFORMATION SOURCES ABOUT THE AUTHOR RELATED BCC REPORTS BCC ONLINE SERVICES DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY	9	Free
EMERGING BBB TECHNOLOGY MARKET KEY DRIVERS KEY CHALLENGES MAJOR TRENDS
Chapter- 3: OVERVIEW	74	Free
TODAY’S PHARMA MARKET BIOLOGICS GENERICS SIGNAL NEED FOR INNOVATION NEUROFOCUSING IN THE PHARMA INDUSTRY EMERGING BBB TECHNOLOGY MARKET BRIEF HISTORY OF BBB BLOOD BRAIN BARRIER DEFINED BBB COMPONENTS BBB ILLUSTRATED MAIN AREAS OF THE BRAIN TREATING DISEASE AND THE BBB BBB TECHNOLOGY CLASSIFICATION MOST COMMON BBB TECHNOLOGY TRANSPORT CONSIDERATIONS BBB TECHNOLOGY DETAILED ENHANCING BIOLOGICAL TRANSPORT SYSTEM TECHNIQUES NANOPARTICLES AND LIPOSOMES PATENTS AND INTELLECTUAL PROTECTION BBB TECHNOLOGY MARKET: PRESENT AND FUTURE DRUG DEVELOPMENT IN THE CNS PROMISING RESEARCH PROMISING CNS DRUGS IN THE PIPELINE FOR POTENTIAL USE WITH BBB TECHNOLOGY
Chapter- 4: C. CRAMER & CO. GMBH	48	Free
ABLYNX NV ADENIOS INC. ALLON THERAPEUTICS INC. ANGIOCHEM INC. ARMAGEN TECHNOLOGIES INC. BIOASIS TECHNOLOGIES INC. BRAINCELLS INC. BRISTOL-MYERS SQUIBB CO. CAPSULUTION PHARMA AG CELLIAL TECHNOLOGIES CYPRESS BIOSCIENCES INC. CENERX BIOPHARMA INC. CEPHALON INC. COGNITION PHARMACEUTICALS LLC. CYTOS BIOTECHNOLOGY AG DIAMEDICA INC. DAINIPPON SUMITOMO PHARMA (DSP) CO LTD. ENVIVO PHARMACEUTICALS INC. ELI LILLY AND CO. GENZYME FABRE-KRAMER PHARMACEUTICALS INC. GERON CORPORATION INSIGHTEC INTERNATIONAL BRAIN BARRIERS SOCIETY (IBBS) IN CEREBRO JANSSEN GLOBAL SERVICES LLC H LUNDBECK A/S MEDGENESIS THERAPEUTIX, INC. (BIOVAIL LAB) MEDIMMUNE MEDINVENT LLC. MITHRIDION INC. NEUROGENETIC PHARMACEUTICALS INC. NEUROVIVE PHARMACEUTICAL AB NSGENE A/S NEUREN PHARMACEUTICALS LTD. OPTINOSE OTSUKA AMERICA PHARMACEUTICAL INC. PROTHERAGEN INC. PFIZER INC. PHARMACO-CELL COMPANY LTD. PHARMIDEX RAPTOR PHARMACEUTICAL CORP. F. HOFFMANN-LA ROCHE LTD. SHIRE PLC SANERON CCEL THERAPEUTICS INC. SOLVO BIOTECHNOLOGY SPENCER PHARMACEUTICAL SOVICELL GMBH SYNAGEVA BIOPHARMA TARGACEPT INC. TETRAGENEX PHARMACEUTICALS INC. TO-BBB TECHNOLOGIES BV TRANSMOLECULAR INC. TTY BIOPHARM UCB VECT-HORUS XENOPORT XIGEN SA

Recent Reports
Top Trending Reports

Related Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - Jan 2011 | Publisher - Jackson Highsmith | Code - BIO079A

The global biologics market is valued at an estimated $149 billion in 2010 and is expected to reach $239 billion by 2015, a compound annual growth rate (CAGR) of 9.9% from 2010-2015. Driving this growth is the need for a more extensive drug pipeline, attractive targets against challenging diseases, a push to pursue biosimilars, and enabling manufacturing technologies that reduce the cost to produce profitable products.

Recent Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Rare Disease Diagnostics: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM227B

The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Softgel Capsules: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM244B

The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

Blood-Brain Barrier Technologies and Global Markets

Report Highlights

Table of Contents

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight